Industry’s Leading Immuno-Oncology Annual Meeting

Join over 675 IO thought leaders at industry's leading Immuno-Oncology event and learn about the latest research in a comprehensive 12-track program, network with decision makers and build lasting collaborations with an international mix of delegates, and gain actionable solutions to drive your organization's next-generation immunotherapy programs.

About the Immuno-Oncology Summit

Over the past 7 years, CHI's Immuno-Oncology Summit has become the leading annual meeting focusing on the latest applied research, providing comprehensive and in-depth coverage across all modalities and stages in the pipeline, including immunomodulatory antibody engineering and emerging immuno-oncology targets and next-gen immunotherapeis, combination immunotherapy, preclinical and translational IO, predictive biomarkers, adoptive T cell therapy, oncolytic viruses and personalized cancer vaccines. The Immuno-Oncology Summit is a perfect meeting place to share experience, foster collaborations, evaluate emerging technologies, and drive innovation in your immuno-oncology programs. Now in its 7th year, the IO Summit consistently delivers a cutting-edge agenda, 675+ senior delegates, and a sold-out exhibit hall.

Please join us in Boston for comprehensive scientific coverage and unparalleled networking opportunities at CHI’s Immuno-Oncology Summit 2019!


Why attend CHI’s Immuno-Oncology Summit?

with 675+ IO thought leaders from 28 countries and 400 companies

the latest developments in immuno-oncology from 175+ scientific presentations and 40+ posters

your comprehensive 5-day program by selecting from 12-tracks, 2 training seminars, partnering forum and 4 courses

at the industry’s leading Immuno-Oncology meeting, with 72% of delegates from biotech and pharma

and build lasting business relationships with IO decision-makers: 46% of delegates are executive/director level

your projects with technology solutions from 40+ exhibitors and 20+ technical presentations

actionable solutions at the expertly-facilitated roundtable discussions

on your agenda by track hopping between concurrent tracks

your research by presenting a scientific poster

Emerging Company Showcase

The Immuno-Oncology Investing and Partnering Forum will play host to an Emerging Company Showcase as part of the program agenda. This showcase allows immuno-oncology companies to pitch their drug, device, diagnostic, or software to an audience of investors, CEOs, and executives in the field.


Connect With Us


For meeting questions or suggestions, please contact:

Julia Boguslavsky
Executive Director, Conferences
Cambridge Healthtech Institute


For partnering and sponsorship info, please contact:

Rod Eymael
Manager, Business Development
Cambridge Healthtech Institute
+1 781.247.6286


For media and association partnerships, please contact:

Pete DeOlympio
Sr. Marketing Manager
Cambridge Healthtech Institute
+1 781.972.5415